Analyst
Jefferies
Equibles does not estimate personal net worth.
Akash Shawari is recorded as Analyst at Jefferies. Akash Shawari has spoken on 2 earnings calls and 3 other investor events across 3 companies, most recently for Merck & Co., Inc. on June 4, 2026. Those appearances were for Arvinas, Inc. (ARVN), Merck & Co., Inc. (MRK) and Spyre Therapeutics, Inc. (SYRE). The companies whose calls Akash Shawari spoke on are classified in the Healthcare sector.
“I head our farm and biotech efforts here on the research side for Jefferies. Joining us is Merck, a company that really, global company with, you know, focused on multiple disease areas.”
“I head our farm and biotech efforts on the research side here at Jefferies. We are in beautiful Times Square, and this is day one of our public portion of our health care conference.”
“I'm a farm and biotech analyst here at Jeffrey's, and I have the pleasure of hosting the Arvinus management team. Randy, why don't I hand it off to you for some intro remarks, and we'll get started.”
“I'm a farm and biotech analyst here at Jeffrey's, and I have the pleasure of hosting the Arvinus management team. Randy, why don't I hand it off to you for some intro remarks, and we'll get started.”
“I'm a farm and biotech analyst here at Jeffrey's, and I have the pleasure of hosting the Arvinus management team. Randy, why don't I hand it off to you for some intro remarks, and we'll get started.”
Jefferies
Analyst
Transcript header (unverified)
ARVN
Biotechnology · Healthcare
Drug Manufacturers - General · Healthcare
